{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:13:07Z","timestamp":1783973587837,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-024-03507-5","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:02:16Z","timestamp":1729508536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The impact of adrenocortical carcinoma hormone secreting status as a predictor of poor survival: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"409","author":[{"given":"Constantinos","family":"Nastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Papaconstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paspala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Pararas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Vryonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Pikouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Chronopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lechou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Pikoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"3507_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.14740\/JOCMR3503W","volume":"10","author":"E Sharma","year":"2018","unstructured":"Sharma E, Dahal S, Sharma P et al (2018) The characteristics and trends in Adrenocortical Carcinoma: a United States Population based study. J Clin Med Res 10:636. https:\/\/doi.org\/10.14740\/JOCMR3503W","journal-title":"J Clin Med Res"},{"key":"3507_CR2","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/J.EJCA.2013.02.034","volume":"49","author":"TMA Kerkhofs","year":"2013","unstructured":"Kerkhofs TMA, Verhoeven RHA, Van Der Zwan JM et al (2013) Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer 49:2579\u20132586. https:\/\/doi.org\/10.1016\/J.EJCA.2013.02.034","journal-title":"Eur J Cancer"},{"key":"3507_CR3","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"A Ebbehoj","year":"2020","unstructured":"Ebbehoj A, Li D, Kaur RJ et al (2020) Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 8:894\u2013902. https:\/\/doi.org\/10.1016\/S2213-8587(20)30314-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3507_CR4","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/ANNONC\/MDV329","volume":"26","author":"R Lib\u00e9","year":"2015","unstructured":"Lib\u00e9 R, Borget I, Ronchi CL et al (2015) Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the study of adrenal tumor (ENSAT) study. Ann Oncol 26:2119\u20132125. https:\/\/doi.org\/10.1093\/ANNONC\/MDV329","journal-title":"Ann Oncol"},{"key":"3507_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/J.EJCA.2009.12.007","volume":"46","author":"G Lughezzani","year":"2010","unstructured":"Lughezzani G, Sun M, Perrotte P et al (2010) The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a north American validation. Eur J Cancer 46:713\u2013719. https:\/\/doi.org\/10.1016\/J.EJCA.2009.12.007","journal-title":"Eur J Cancer"},{"key":"3507_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1530\/EJE-18-0450","volume":"179","author":"T Vanbrabant","year":"2018","unstructured":"Vanbrabant T, Fassnacht M, Assie G, Dekkers OM (2018) Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis. Eur J Endocrinol 179:429\u2013436. https:\/\/doi.org\/10.1530\/EJE-18-0450","journal-title":"Eur J Endocrinol"},{"key":"3507_CR7","doi-asserted-by":"publisher","first-page":"106908","DOI":"10.1016\/J.INFSOF.2022.106908","volume":"147","author":"C Wohlin","year":"2022","unstructured":"Wohlin C, Kalinowski M, Romero Felizardo K, Mendes E (2022) Successful combination of database search and snowballing for identification of primary studies in systematic literature studies. Inf Softw Technol 147:106908. https:\/\/doi.org\/10.1016\/J.INFSOF.2022.106908","journal-title":"Inf Softw Technol"},{"key":"3507_CR8","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583","journal-title":"PLoS Med"},{"key":"3507_CR9","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355. https:\/\/doi.org\/10.1136\/BMJ.I4919","DOI":"10.1136\/BMJ.I4919"},{"key":"3507_CR10","doi-asserted-by":"publisher","unstructured":"T\u0151ke J, Uhlyarik A, Lohinszky J et al (2022) Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series. Front Endocrinol (Lausanne) 13. https:\/\/doi.org\/10.3389\/FENDO.2022.952418","DOI":"10.3389\/FENDO.2022.952418"},{"key":"3507_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1210\/CLINEM\/DGAC046","volume":"107","author":"M Daher","year":"2022","unstructured":"Daher M, Varghese J, Gruschkus SK et al (2022) Temporal trends in outcomes in patients with Adrenocortical Carcinoma: a multidisciplinary referral-center experience. J Clin Endocrinol Metab 107:1239\u20131246. https:\/\/doi.org\/10.1210\/CLINEM\/DGAC046","journal-title":"J Clin Endocrinol Metab"},{"key":"3507_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/J.SURG.2019.04.066","volume":"167","author":"A Sada","year":"2020","unstructured":"Sada A, Asaad M, Bews KA et al (2020) Comparison between functional and non-functional adrenocortical carcinoma. Surgery 167:216\u2013223. https:\/\/doi.org\/10.1016\/J.SURG.2019.04.066","journal-title":"Surgery"},{"key":"3507_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/J.JAMCOLLSURG.2015.12.013","volume":"222","author":"LM Postlewait","year":"2016","unstructured":"Postlewait LM, Ethun CG, Tran TB et al (2016) Outcomes of adjuvant mitotane after resection of Adrenocortical Carcinoma: a 13-Institution study by the US Adrenocortical Carcinoma Group. J Am Coll Surg 222:480\u2013490. https:\/\/doi.org\/10.1016\/J.JAMCOLLSURG.2015.12.013","journal-title":"J Am Coll Surg"},{"key":"3507_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/J.SURG.2014.08.047","volume":"156","author":"M Livhits","year":"2014","unstructured":"Livhits M, Li N, Yeh MW, Harari A (2014) Surgery is associated with improved survival for adrenocortical cancer, even in metastatic disease. Surgery 156:1531\u20131541. https:\/\/doi.org\/10.1016\/J.SURG.2014.08.047","journal-title":"Surgery"},{"key":"3507_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/J.EURURO.2013.11.006","volume":"65","author":"A Berruti","year":"2014","unstructured":"Berruti A, Fassnacht M, Haak H et al (2014) Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Eur Urol 65:832\u2013838. https:\/\/doi.org\/10.1016\/J.EURURO.2013.11.006","journal-title":"Eur Urol"},{"key":"3507_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1530\/EJE-13-0519","volume":"169","author":"M Ayala-Ramirez","year":"2013","unstructured":"Ayala-Ramirez M, Jasim S, Feng L et al (2013) Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol 169:891\u2013899. https:\/\/doi.org\/10.1530\/EJE-13-0519","journal-title":"Eur J Endocrinol"},{"key":"3507_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1245\/S10434-009-0716-X","volume":"17","author":"EG Grubbs","year":"2010","unstructured":"Grubbs EG, Callender GG, Xing Y et al (2010) Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol 17:263\u2013270. https:\/\/doi.org\/10.1245\/S10434-009-0716-X","journal-title":"Ann Surg Oncol"},{"key":"3507_CR18","doi-asserted-by":"publisher","unstructured":"Sada A, Foster TR, Al-Ward R et al (2024) The effect of hormonal secretion on survival in adrenocortical carcinoma: a multi-center study. Surgery 175. https:\/\/doi.org\/10.1016\/J.SURG.2023.04.070","DOI":"10.1016\/J.SURG.2023.04.070"},{"key":"3507_CR19","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/J.AMJSURG.2015.09.020","volume":"211","author":"GA Margonis","year":"2016","unstructured":"Margonis GA, Kim Y, Tran TB et al (2016) Outcomes after resection of cortisol-secreting adrenocortical carcinoma. Am J Surg 211:1106\u20131113. https:\/\/doi.org\/10.1016\/J.AMJSURG.2015.09.020","journal-title":"Am J Surg"},{"key":"3507_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/JC.2013-2856","volume":"99","author":"T Else","year":"2014","unstructured":"Else T, Williams AR, Sabolch A et al (2014) Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma. J Clin Endocrinol Metab 99:455\u2013461. https:\/\/doi.org\/10.1210\/JC.2013-2856","journal-title":"J Clin Endocrinol Metab"},{"key":"3507_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/FENDO.2016.00099","volume":"7","author":"C Scollo","year":"2016","unstructured":"Scollo C, Russo M, Trovato MA et al (2016) Prognostic factors for Adrenocortical Carcinoma outcomes. Front Endocrinol (Lausanne) 7:25. https:\/\/doi.org\/10.3389\/FENDO.2016.00099","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3507_CR22","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1111\/JCMM.16936","volume":"25","author":"JJ Baechle","year":"2021","unstructured":"Baechle JJ, Hanna DN, Sekhar KR et al (2021) Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma. J Cell Mol Med 25:10061\u201310072. https:\/\/doi.org\/10.1111\/JCMM.16936","journal-title":"J Cell Mol Med"},{"key":"3507_CR23","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-18-0608","volume":"179","author":"M Fassnacht","year":"2018","unstructured":"Fassnacht M, Dekkers OM, Else T et al (2018) European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the study of adrenal tumors. Eur J Endocrinol 179:G1\u2013G46. https:\/\/doi.org\/10.1530\/EJE-18-0608","journal-title":"Eur J Endocrinol"},{"key":"3507_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/A-2042-2431","volume":"55","author":"SO David","year":"2023","unstructured":"David SO, Krieg S, Esposito I et al (2023) A revised version of the TNM classification leads to optimized predictive performance in patients with Adrenocortical Carcinoma. Horm Metab Res 55:227\u2013235. https:\/\/doi.org\/10.1055\/A-2042-2431","journal-title":"Horm Metab Res"},{"key":"3507_CR25","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/J.SURG.2014.08.018","volume":"156","author":"EA Asare","year":"2014","unstructured":"Asare EA, Wang TS, Winchester DP et al (2014) A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I\/II disease. Surgery 156:1378\u20131386. https:\/\/doi.org\/10.1016\/J.SURG.2014.08.018","journal-title":"Surgery"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-024-03507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-024-03507-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-024-03507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:02:14Z","timestamp":1729656134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-024-03507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3507"],"URL":"https:\/\/doi.org\/10.1007\/s00423-024-03507-5","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"17 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"COI\/disclosures"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}